Clinical trials in Galati

Innovative research focusing on Type 2 Diabetes and metabolic conditions, evaluating new therapeutic approaches including tirzepatide and orforglipron treatments. Studies aim to improve glycemic control and assess cardiovascular outcomes.

• Type 2 Diabetes Management
• Glycemic Control Optimization
• Cardiovascular Risk Assessment

Multiple trials are exploring combination therapies with existing treatments like insulin glargine.

Clinical investigations centered on Systemic Lupus Erythematosus, testing novel treatments including dapirolizumab pegol and BMS-986165 to evaluate long-term safety and efficacy.

• Lupus Treatment Innovation
• Long-term Safety Studies
• Immune System Modulation

Research focuses on developing sustainable treatment options for chronic autoimmune conditions.

Comprehensive studies addressing Non-alcoholic Steatohepatitis and chronic hepatitis conditions, investigating innovative treatments including semaglutide and bepirovirsen.

• Liver Disease Management
• NASH Treatment
• Hepatitis B Therapy

Trials aim to improve liver histology and reduce disease progression.

Advanced research on obesity and related conditions, studying new therapeutic options including retatrutide for weight management and associated complications.

• Obesity Treatment
• Weight Management Solutions
• Metabolic Health Optimization

Studies include evaluation of treatments for obesity-related conditions like knee osteoarthritis.

Innovative research addressing Major Depressive Disorder with a focus on anhedonia, testing new adjunctive therapies like aticaprant alongside traditional antidepressants.

• Depression Treatment
• Relapse Prevention
• Combination Therapy Approaches

Studies aim to enhance treatment outcomes for patients with moderate-to-severe symptoms.